Health System Responses to the Women's Health Initiative Findings on Estrogen and Progestin: Organizational Response
Authors:
- Cynthia L. HartsfieldCHCynthia L. Hartsfield
- Maureen T. ConnellyMCMaureen T. Connelly
- Katherine M. NewtonKNKatherine M. Newton
- Susan E. AndradeSASusan E. Andrade
- Feifei WeiFWFeifei Wei
- Diana S. M. BuistDBDiana S. M. Buist
Open Access
- 1 November 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI Monographs
- Vol. 2005 (35) , 113-115
Abstract
Recent randomized trials have indicated that the risks of hormone therapy for menopausal women may outweigh the benefits. The purpose of this study was to describe how health plans responded to the findings of the Women's Health Initiative (WHI) estrogen plus progestin trial. We surveyed five health plans affiliated with the HMO Research Network and the Cancer Research Network to document the response of each plan to the WHI in terms of patient and provider education and guidelines. Every health plan issued responses within 3 months of WHI's termination in a variety of formats. Recommendations were relatively consistent across the organizations. Given the documented changes in hormone therapy use in these five health plans in the post-WHI era, we conclude that attempts on the part of each organization to educate patients and providers about the implications of the WHI may have contributed to the observed changes in hormone therapy use.Keywords
This publication has 9 references indexed in Scilit:
- Hormone Therapy Prescribing Patterns in the United StatesObstetrics & Gynecology, 2004
- Estrogen Therapy and Risk of Cardiovascular Events Among Women With Type 2 DiabetesDiabetes Care, 2003
- Hormone Replacement Therapy and Cognition: Systematic Review and Meta-AnalysisObstetrical & Gynecological Survey, 2001
- Hormone Replacement Therapy and Alzheimer's Disease: An Update on the IssuesHealth Care for Women International, 1999
- Prescribing Hormone Replacement Therapy for Menopausal SymptomsAnnals of Internal Medicine, 1999
- Patient-Identified Needs for Hormone Replacement Therapy Counseling: A Qualitative StudyAnnals of Internal Medicine, 1999
- Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysisThe American Journal of Medicine, 1999
- Hormone Therapy To Prevent Disease and Prolong Life in Postmenopausal WomenAnnals of Internal Medicine, 1992
- 91300401 Postmenopausal estrogen therapy and cardiovascular disease — Ten-year follow-up from the nurses' health studyMaturitas, 1992